The relation between mitogen activated protein kinase (MAPK) pathway and different genes expression in patients with beta Thalassemia

• Main Authors: Yasser AbdElsattar Elghobashy, Mohamed FA. Assar, Asmaa A. Mahmoud, Abdel Monem A Eltorgoman, Saher Elmasry
• Format: Article
• Language: English
• Published: Elsevier 2020-12-01
• Series: Biochemistry and Biophysics Reports
• Subjects: β thalassemia; MAPK pathway; ARRB1; GNAI2 and DUSP5
• Online Access: http://www.sciencedirect.com/science/article/pii/S2405580820301461

Background: β-thalassemia is an inherited hemoglobinopathy resulting in quantitative changes in the β-globin chain. Understanding the molecular basis of that disorder requires studying the expression of genes controlling the pathways that affect the erythropoietic homeostasis especially the MAPK pathway. The MAPKs are a family of serine/threonine kinases that play an essential role in connecting cell-surface receptors to DNA in the nucleus of the cell. Aim: to study the effect of expression of GNAI2, DUSP5 and ARRB1 genes on MAPK signaling pathway in pediatric patients with beta thalassemia. Methods: Forty children with beta thalassemia major (TM), forty children with beta thalassemia intermedia (TI) and forty age and gender matched healthy controls were enrolled in this study. Detection of GNAI2, DUSP5 and ARRB1 mRNA expression was done by real time polymerase chain reaction (RT-PCR). Results: revealed increased expression of ARRB1 (Arrestin Beta 1) gene, and decreased expression of both GNAI2 (Guanine nucleotide-binding protein G (i) subunit alpha-2) and DUSP5 (Dual specificity protein phosphatase 5) genes in both patient groups than control groups respectively. Conclusions: Change in the rate of expression of ARRB1, GNAI2 and DUSP5 may have a role in the pathogenesis of abnormal hematopoiesis in cases of β thalassemia through affecting the MAPK pathway.